Healthconn Corp.

6665

TW0006665003

Advanced Medical Equipment & Technology

End-of-day quote Taipei Exchange Other stock markets 06:00:00 2024-04-25 pm EDT			5-day change	1st Jan Change
27.35 ^TWD	+3.80%		+5.19%	-4.04%

2023	Healthconn Corp. Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	Healthconn Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	CI

Healthconn Corp.(GTSM:6665) added to S&P Global BMI Index

March 19, 2018 at 12:00 am EDT

Latest news about Healthconn Corp.

Healthconn Corp. Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-13	CI
Healthconn Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-25	CI
Healthconn Corp. Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-11	CI
Healthconn Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-04-18	CI
Healthconn Corp. Reports Earnings Results for the Half Year Ended June 30, 2021	21-08-12	CI
Healthconn Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-04-18	CI
Healthconn Corp. Reports Earnings Results for the Half Year Ended June 30, 2020	20-08-11	CI
Healthconn Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-23	CI
Healthconn Corp. Reports Earnings Results for the Half Year Ended June 30, 2019	19-08-12	CI
Healthconn Corp. Reports Earnings Results for the Full Year Ended December 31, 2018	19-04-25	CI
Healthconn Corp.(GTSM:6665) dropped from S&P Global BMI Index	18-09-24	CI
Healthconn Corp.(GTSM:6665) added to S&P Global BMI Index	18-03-19	CI

HEALTHCONN CORP. is a Taiwan-based Company mainly engaged in the provision of disease prevention and treatment services. The Company is engaged in the provision of precisely prevent medical integration services, molecular biology testing programs and accurate diagnostic testing services. The precisely prevent medical integration services include precisely prevention, disease management and health promotion services. The molecular bioassay services include food safety testing and functional medical testing services. The accurate diagnostic testing services include molecular testing and clinical microbiological testing services, as well as the development and operation of medical health institutions. The Company is also engaged in the medical equipment sale business. The Company operates in the Taiwan market as well as in the mainland China market.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Advanced Medical Equipment Wholesale

	1st Jan change	Capi.
HEALTHCONN CORP.	-4.04%	38.02M
CHC HEALTHCARE GROUP	-8.67%	287M
ILEX MEDICAL LTD	+13.93%	198M
MEDTECHNICA LTD.	+26.13%	77.74M
MEDICAL IMAGING CORPORATION	+20.48%	65.76M